BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15246248)

  • 21. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors.
    Yu N; Atienza JM; Bernard J; Blanc S; Zhu J; Wang X; Xu X; Abassi YA
    Anal Chem; 2006 Jan; 78(1):35-43. PubMed ID: 16383308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid binding receptors and their physiological role in type 2 diabetes.
    Swaminath G
    Arch Pharm (Weinheim); 2008 Dec; 341(12):753-61. PubMed ID: 19009545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.
    Gloriam DE; Foord SM; Blaney FE; Garland SL
    J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
    Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
    Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of GPCRs by peptide ligands and membrane compartments theory: structural studies of endogenous peptide hormones in membrane environment.
    Sankararamakrishnan R
    Biosci Rep; 2006 Apr; 26(2):131-58. PubMed ID: 16773462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detailed knowledge of cellular expression of G protein-coupled receptors in the human enteric nervous system is essential for understanding their diverse actions.
    van Nassauw L; Timmermans JP
    Neurogastroenterol Motil; 2010 Sep; 22(9):959-64. PubMed ID: 20701687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
    Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvements in G protein-coupled receptor purification yield light stable rhodopsin crystals.
    Salom D; Le Trong I; Pohl E; Ballesteros JA; Stenkamp RE; Palczewski K; Lodowski DT
    J Struct Biol; 2006 Dec; 156(3):497-504. PubMed ID: 16837211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into GPCR function: implications for HTS.
    Eglen RM; Reisine T
    Methods Mol Biol; 2009; 552():1-13. PubMed ID: 19513638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs.
    Hsu SH; Luo CW
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1021-9. PubMed ID: 17652154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors.
    Wheatley M; Simms J; Hawtin SR; Wesley VJ; Wootten D; Conner M; Lawson Z; Conner AC; Baker A; Cashmore Y; Kendrick R; Parslow RA
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):717-20. PubMed ID: 17635132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands.
    Weill N; Rognan D
    J Chem Inf Model; 2009 Apr; 49(4):1049-62. PubMed ID: 19301874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two ligands for a GPCR, proton vs lysolipid.
    Im DS
    Acta Pharmacol Sin; 2005 Dec; 26(12):1435-41. PubMed ID: 16297340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effects of anesthetics on G-protein-coupled receptors].
    Minami K; Uezono Y
    Masui; 2005 Feb; 54(2):118-25. PubMed ID: 15747504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.
    Seifert R; Dove S
    Mol Pharmacol; 2009 Jan; 75(1):13-8. PubMed ID: 19001067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors.
    Lohse MJ; Nikolaev VO; Hein P; Hoffmann C; Vilardaga JP; Bünemann M
    Trends Pharmacol Sci; 2008 Mar; 29(3):159-65. PubMed ID: 18262662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysophospholipids as mediators of immunity.
    Lin DA; Boyce JA
    Adv Immunol; 2006; 89():141-67. PubMed ID: 16682274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.